coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, according to news agency Reuters reported.
The expert committee set up by Drugs Controller General of India (DCGI) V.G. Somani to vet vaccine proposals, met for the second time this week, recommended emergency approval for Oxford-AstraZeneca COVID-19 vaccine.
British-Swedish drugmaker inked an agreement with Serum Institute of India to produced 1 billion doses of its experimental vaccine for lower-and-middle income countries.Dubbed as Covishield in India, the Oxford-AstraZeneca COVID-19 vaccine showed an average efficacy of 70.4%, with no hospitalisations or severe disease, the researchers claimed.